StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$2.83+0.06 (+2.17%)

Close on Oct 19, 2026Market cap $2.26MP/E –Yield –

PMGC gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

PMGC's gross profit for the twelve months ending Sep 30, 2026 was $1.32M. For fiscal 2025 it was $185.31K, down 83.7% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$185.31K-83.7%
FY2023Dec 31, 2023$1.13M+153.6%
FY2022Dec 31, 2022$447.31K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$601.44K+670.8%
Q2 FY2026Jun 30, 2026$385.69K-2.1%
Q1 FY2026Mar 31, 2026$230.47K-47.5%
Q4 FY2025Dec 31, 2025$107.28K-75.9%
Q3 FY2025Sep 30, 2025$78.03K-83.1%
Q3 FY2024Sep 30, 2024$393.90K+7.6%
Q2 FY2024Jun 30, 2024$439.25K+110.8%
Q1 FY2024Mar 31, 2024$445.65K+353.0%
Q4 FY2023Dec 31, 2023$461.70K–
Q3 FY2023Sep 30, 2023$366.15K-99.8%
Q2 FY2023Jun 30, 2023$208.35K–
Q1 FY2023Mar 31, 2023$98.39K–
Q4 FY2022Dec 31, 2022-$353.45M–
Q3 FY2022Sep 30, 2022$237.69M–

More PMGC figures

See a number that looks wrong?